Long intergenic non-protein coding RNA 1392 (LINC01392)

Long intergenic non-protein coding RNA 1392 (LINC01392) is part of the lincRNA class, which includes large, autonomously transcribed RNA molecules that do not encode proteins and are generally located in gene deserts—regions of the genome not overlapping annotated protein-coding genes[1][3][5]. LincRNAs such as LINC01392 can fine-tune gene expression, influence chromatin architecture, and participate in regulatory processes both near their genomic loci (cis) or at distant sites (trans)[5][7][9]. While the broader lincRNA group is increasingly recognized for regulatory roles in cellular differentiation, cancer, metabolism, and neurological diseases[5][7][9], there is currently no direct functional or therapeutic evidence linking LINC01392 to specific diseases or drug responses in humans. Its primary biological significance is as a non-coding RNA locus identified in genetic association studies, rather than as an established therapeutic target or biomarker[1][6][10]. There is no evidence of misspelling or incorrect annotation for this target; however, it is important to note that LINC01392 is not a traditional therapeutic target such as a receptor, enzyme, transporter, or transcription factor. It serves as a regulatory non-coding RNA gene[3][5].

Other names

LINC01392